Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1
申请人:Amgen Inc.
公开号:US07666888B2
公开(公告)日:2010-02-23
Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder:
wherein the variables A-B, R1, R2, m, and Q are described herein.